Abstract
THE enzyme monoamine oxidase (monoamine : O2 oxido-reductase (deaminating), EC 1.4.3.4) (MAO) is likely to be concerned in the metabolism of known or suspected central nervous system transmitters such as nor adrenaline, dopamine and 5-hydroxytryptamine. In the therapy of depressive disease, drugs are used which are able to inhibit MAO and it is thought that they owe their beneficial effect to this ability and to the resulting accumulation of amines. It is found, however, that some compounds belonging to this group are considerably more effective therapeutically than others1,2 and no fully satisfactory explanation has been offered. We now offer an approach which we think in better accord with the characteristics of MAO.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Davis, J. M., Arch. Gen. Psychiat., 13, 552 (1965).
Hendley, E. D., and Snyder, S. H., Nature, 220, 1330 (1968).
Gorkin, V. Z., Pharmacol. Rev., 18, 115 (1966).
Squires, R. F., Biochem. Pharmacol., 17, 1401 (1968).
Youdim, M. B. H., and Sandler, M., Biochem. J., 105, 43P (1967).
Collins, G. G. S., Youdim, M. B. H., and Sandler, M., FEBS Lett., 1, 215 (1968).
Youdim, M. B. H., Collins, G. G. S., and Sandler, M. (edit. by Shugar, D.), Proc. Annual FEBS Meeting, Praha, 1968 (Academic Press, New York, in the press).
Kim, H. C., and D'Iorio, A., Canad. J. Biochem., 46, 295 (1968).
Ragland, J. B., Biochem. Biophys. Res. Commun., 31, 203 (1968).
Hartman, B., Kloepter, H., and Yasunobu, K., Fed. Proc., 28, 857 (1969).
Gomes, B., Igaue, I., Kloepfer, H. G., and Yasunobu, K. T., Arch. Biochem. Biophys., 132, 16 (1969).
Tipton, K. F., and Spires, I. P. C., Biochem. Pharmacol., 17, 2137 (1968).
Johnson, J. P., Biochem. Pharmacol., 17, 1285 (1968).
Hawkins, J., Biochem. J., 50, 577 (1952).
Youdim, M. B. H., and Sourkes, T. L., Canad. J. Biochem., 43, 1305 (1965).
Andrews, P., Biochem. J., 91, 222 (1964).
Tipton, K. F., Europ. J. Biochem., 4, 103 (1968).
Glenner, G. C., Burtner, H. J., and Brown, G. W., J. Histochem. Cytochem., 5, 591 (1957).
Kraml, M., Biochem. Pharmacol., 14, 1684 (1965).
Robinson, D. S., Lovenberg, W., Keiser, H., and Sjoerdsma, A., Biochem. Pharmacol., 17, 109 (1968).
Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J., J. Biol Chem., 193, 265 (1951).
Erwin, V. G., and Hellerman, L., J. Biol. Chem., 242, 4230 (1967).
Taylor, J. D., Wykes, A. A., Gladish, Y. C., and Martin, W. B., Nature, 187, 941 (1960).
Udenfriend, S., Witkop, B., Redfield, B. G., and Weissbach, H., Biochem. Pharmacol., 1, 160 (1958).
Poirier, L. J., Singh, P., and Boucher, R., Canad. J. Physiol. Pharmacol., 46, 585 (1968).
Gorkin, V. Z., Tat'yanenko, L. V., Krasnokutskaya, D. M., Pronina, E. V., and Yakhontov, L. N., Biokhimiya, 32, 510 (1967).
Schnaitman, C., Erwin, V. G., and Greenawalt, J. W., J. Cell Biol., 32, 719 (1967).
Dixon, M., and Webb, E. C., Enzymes, second ed. (Longmans, London, 1963).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
YOUDIM, M., COLLINS, G. & SANDLER, M. Multiple Forms of Rat Brain Monoamine Oxidase. Nature 223, 626–628 (1969). https://doi.org/10.1038/223626a0
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1038/223626a0
This article is cited by
-
Monoamine oxidase isoenzymes: genes, functions and targets for behavior and cancer therapy
Journal of Neural Transmission (2018)
-
Cadmium Neurotoxicity to a Freshwater Planarian
Archives of Environmental Contamination and Toxicology (2014)
-
Gaddum and LSD: the birth and growth of experimental and clinical neuropharmacology research on 5‐HT in the UK
British Journal of Pharmacology (2008)
-
Monoamine Oxidases: From Tissue Homogenates to Transgenic Mice
Neurochemical Research (2007)
-
Increased life expectancy resulting from addition of l-deprenyl to Madopar� treatment in Parkinson's disease: A longterm study
Journal of Neural Transmission (1985)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.